6s60
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='6s60' size='340' side='right'caption='[[6s60]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='6s60' size='340' side='right'caption='[[6s60]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6s60]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[6s60]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6S60 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6S60 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=KX8:4-[3-(3,4-dichlorophenyl)-4-[(phenylmethyl)carbamoyl]pyrazol-1-yl]butanoic+acid'>KX8</scene>, <scene name='pdbligand=MYR:MYRISTIC+ACID'>MYR</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=KX8:4-[3-(3,4-dichlorophenyl)-4-[(phenylmethyl)carbamoyl]pyrazol-1-yl]butanoic+acid'>KX8</scene>, <scene name='pdbligand=MYR:MYRISTIC+ACID'>MYR</scene></td></tr> | |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6s60 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s60 OCA], [https://pdbe.org/6s60 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6s60 RCSB], [https://www.ebi.ac.uk/pdbsum/6s60 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6s60 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6s60 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6s60 OCA], [https://pdbe.org/6s60 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6s60 RCSB], [https://www.ebi.ac.uk/pdbsum/6s60 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6s60 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/TEAD2_HUMAN TEAD2_HUMAN] Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds to the SPH and GT-IIC 'enhansons' (5'-GTGGAATGT-3'). May be involved in the gene regulation of neural development. Binds to the M-CAT motif.<ref>PMID:18579750</ref> <ref>PMID:19324877</ref> | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 23: | Line 23: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Allemand | + | [[Category: Allemand F]] |
- | [[Category: Guichou | + | [[Category: Guichou JF]] |
- | [[Category: Sturbaut | + | [[Category: Sturbaut M]] |
- | + | ||
- | + | ||
- | + |
Current revision
Crystal structure of hTEAD2 in complex with a trisubstituted pyrazole inhibitor
|